Evaluation of Bcl-2, Mcl-1, and Bax as Potential Biomarkers in Chemo Radiotherapy Induced Oral Mucositis in Head and Neck Cancer Patients: A Pilot Study
Background: Oral mucositis (OM) is an acute debilitating side effects of chemoradiotherapy (CRT) in head and neck cancer (HNC) patients. Salivary biomarkers are noninvasive and aid in early diagnosis and disease prevention. Objective: This study analyzed Bcl-2, Mcl-1, and Bax as potential biomarkers...
Saved in:
Main Authors: | R Deepika (Author), Sreedevi Dharman (Author), Selvaraj Jayaraman (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial)
by: Basma Elsaadany, et al.
Published: (2024) -
Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
by: Elainy Patricia Lino Gasparotto, et al.
Published: (2011) -
The Effect of Coffee in the Prevention of Oral Mucositis Associated with Head and Neck Radiotherapy
by: Emel Emine Kayikci, et al.
Published: (2023) -
Experience of radiotherapy in head and neck
by: Dhiancarlo Rocha MACEDO, et al.
Published: (2019) -
Effectiveness of prophylactic agents in prevention of oral mucositis in patients with head and neck cancer receiving radiotherapy
by: Shukria M Al-Zahawi, et al.
Published: (2013)